The Relationship between IL-10 Levels and Cardiovascular Events in Patients with CKD

dc.authorid0000-0003-0592-7828
dc.authorid0000-0002-8785-4820
dc.authorid0000-0003-4763-2024
dc.contributor.authorYilmaz, Mahmut Ilker
dc.contributor.authorSolak, Yalcin
dc.contributor.authorSaglam, Mutlu
dc.contributor.authorCayci, Tuncer
dc.contributor.authorAcikel, Cengizhan
dc.contributor.authorUnal, Hilmi Umut
dc.contributor.authorEyileten, Tayfun
dc.date.accessioned2025-05-10T19:35:42Z
dc.date.issued2014
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBackground and objectives Cardiovascular disease is the leading cause of death in patients with CKD. IL-10 is considered an antiatherosclerotic cytokine. However, previous studies have failed to observe an association between IL40 and cardiovascular disease in CKD. This study aimed to evaluate whether serum IL-10 levels were associated with the risk of cardiovascular events in CKD patients. Design, setting, participants, & measurements Four hundred three patients with stages 1-5 CKD were followed for a mean of 38 (range=2-42) months for fatal and nonfatal cardiovascular events. IL-10 and IL-6 were measured at baseline together with surrogates of endothelial function (flow-mediated dilatation) and proinflammatory markers (high-sensitivity C-reactive protein and pentraxin-3). The association between IL-10 and flow-mediated dilatation through linear regression analyses was evaluated. The association between IL-10 and the risk of cardiovascular events was assessed with Cox regression analysis. Results IL-10, IL-6, high-sensitivity C-reactive protein, and pentraxin-3 levels were higher among participants with lower eGFR. Both fatal (25 of 200 versus 6 of 203 patients) and combined fatal and nonfatal (106 of 200 versus 23 of 203 patients) cardiovascular events were more common in patients with IL-10 concentration above the median. Flow-mediated dilatation was significantly lower in patients with higher serum IL-10 levels, but IL-10 was not associated with flow-mediated dilatation in multivariate analysis. Kaplan Meier survival curves showed that patients with IL-10 below the median value (<21.5 pg/ml) had higher cumulative survival compared with patients who had IL-10 levels above the median value (log-rank test, P<0.001). Conclusions IL-10 levels increase along with the reduction of kidney function. Higher serum IL-10 levels were associated with the risk of cardiovascular events during follow-up. We speculate that higher IL-10 levels in this context signify an overall proinflammatory milieu.
dc.description.sponsorshipGulhane School of Medicine; Swedish Research Council
dc.description.sponsorshipWe acknowledge support from the Gulhane School of Medicine and the Swedish Research Council.
dc.identifier.doi10.2215/CJN.08660813
dc.identifier.endpage1216
dc.identifier.issn1555-9041
dc.identifier.issn1555-905X
dc.identifier.issue7
dc.identifier.pmid24789549
dc.identifier.scopus2-s2.0-84923788718
dc.identifier.scopusqualityQ1
dc.identifier.startpage1207
dc.identifier.urihttps://doi.org/10.2215/CJN.08660813
dc.identifier.urihttps://hdl.handle.net/20.500.14730/8942
dc.identifier.volume9
dc.identifier.wosWOS:000338615300011
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAmer Soc Nephrology
dc.relation.ispartofClinical Journal of The American Society of Nephrology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectEndothelial Dysfunction
dc.subjectInterleukin-10
dc.subjectPlasma
dc.subjectArtery
dc.subjectRisk
dc.titleThe Relationship between IL-10 Levels and Cardiovascular Events in Patients with CKD
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
8942.pdf
Boyut:
799.36 KB
Biçim:
Adobe Portable Document Format